A case report of two iatrogenic hypercalcemia incidents following repeated use of calcium sulfate beads in femoral periprosthetic joint infection management
Authors: Ngozika Martha Chidiobi , Rohan Dahiya , Salman Qayum , Jane Edmondson , Aditya Maney
Abstract
Background: Calcium sulfate beads are frequently used in the management of periprosthetic joint infections (PJIs) because of their effectiveness in local antibiotic delivery and bone void filling. However, repeated use can lead to significant complications, including iatrogenic hypercalcemia. Despite reports of this complication in the literature, the cases in this paper demonstrate a relative lack of awareness among physicians.
Cases: We report two cases of iatrogenic hypercalcemia secondary to repeated administration of calcium sulfate beads in the treatment of femoral PJIs, a cause that was initially unrecognized by the medical team.
Case 1: An 83-year-old woman developed severe hypercalcemia requiring intensive medical management following multiple surgeries for chronic femoral PJI that necessitated implantation of calcium beads for antibiotic delivery.
Case 2: An 81-year-old woman developed recurrent hypercalcemia after multiple administrations of calcium sulfate beads for treatment of her periprosthetic fracture.
Conclusion: These cases highlight the potential risk of hypercalcemia associated with the use of calcium sulfate beads and emphasize the need for careful monitoring of serum calcium levels in such patients. They underscore the importance of multidisciplinary collaboration, which was instrumental in determining the etiology in these cases.
Keywords: Iatrogenic hypercalcemia, Calcium sulfate, prosthetic joint infection (PJI), biofilm, arthroplasty, case report.
Pubmed Style
Ngozika Martha Chidiobi, Rohan Dahiya, Salman Qayum, Jane Edmondson, Aditya Maney. A case report of two iatrogenic hypercalcemia incidents following repeated use of calcium sulfate beads in femoral periprosthetic joint infection management. EJMCR. 2026; 12 (March 2026): 104-109. doi:10.24911/ejmcr.9-2385
Publication History
Received: October 07, 2025
Revised: November 17, 2025
Accepted: December 28, 2025
Published: March 12, 2026
Authors
Ngozika Martha Chidiobi
NHS England, Internal Medicine Trainee, Mersey and West Lancashire Teaching Hospital NHS Trust, Northwest Deanery, Manchester, UK.
Rohan Dahiya
Junior Clinical Fellow, General Medicine, Wythenshawe Hospital, Manchester Foundation Trust, Greater Manchester, UK.
Salman Qayum
Junior Clinical Fellow, Respiratory Medicine, Wythenshawe Hospital, Manchester Foundation Trust, Greater Manchester, UK.
Jane Edmondson
Associate Specialist, Orthogeriatrics, Wythenshawe Hospital, Manchester Foundation Trust, Greater Manchester, UK.
Aditya Maney
Consultant Geriatrician/General Internal Medicine, Orthogeriatrics, Wythenshawe Hospital, Manchester Foundation Trust, Greater Manchester, UK.